A phase 2 trial of defibrotide for the prevention of chimeric antigen receptor T-cell–associated neurotoxicity syndrome
- Resource Type
- Article
- Source
- In
Blood Advances 14 November 2023 7(21):6790-6799 - Subject
Lymphoid Neoplasia Clinical Trials and Observations Immunobiology and Immunotherapy - Language
- ISSN
- 2473-9529